Harvard Bioscience (HBIO) Operating Expenses (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Operating Expenses of $13.4 million for Q1 2026, down 78.31% year-over-year from $61.9 million in Q1 2025, and up 7.67% quarter-over-quarter from $12.5 million in Q4 2025.
Harvard Bioscience (HBIO) Operating Expenses (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Operating Expenses for 17 consecutive years, with $13.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses fell 78.31% year-over-year to $13.4 million; the TTM figure through Mar 2026 stood at $50.1 million (down 52.68% YoY), while the FY2025 annual figure was $98.5 million, up 61.52% from the prior year.
- Operating Expenses advanced to $13.4 million in Q1 2026 per HBIO's latest filing, from $12.5 million in the prior quarter.
- Across five years, Operating Expenses topped out at $61.9 million in Q1 2025 and bottomed at $11.8 million in Q3 2025.
- Historically, Operating Expenses has averaged $17.9 million across 5 years, with a median of $15.7 million in 2023.
- Annual changes were most pronounced in 2025 — Operating Expenses surged 262.75% — and 2026, when it plunged 78.31%.
- Harvard Bioscience's Operating Expenses stood at $16.3 million in 2022, then slipped by 1.52% to $16.0 million in 2023, then dropped by 12.73% to $14.0 million in 2024, then retreated by 10.99% to $12.5 million in 2025, then climbed by 7.67% to $13.4 million in 2026.
- Business Quant data shows HBIO's Operating Expenses at $13.4 million in Q1 2026, $12.5 million in Q4 2025, and $11.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.29 Bn | 129.07 Bn | 1.96 Bn | 988.50 Mn |
| 2 | Becton Dickinson | 52.49 Bn | 51.63 Bn | 2.32 Bn | 4.32 Bn |
| 3 | Alcon | 35.74 Bn | 34.38 Bn | 1.68 Bn | 1.63 Bn |
| 4 | Resmed | 33.95 Bn | 32.48 Bn | 861.22 Mn | 412.51 Mn |
| 5 | Medline | 28.95 Bn | 26.27 Bn | 2.22 Bn | 1.82 Bn |
| 6 | West Pharmaceutical Services | 25.04 Bn | 24.60 Bn | 329.20 Mn | 137.30 Mn |
| 7 | Solventum | 15.32 Bn | 14.92 Bn | 1.29 Bn | 1.11 Bn |
| 8 | Cooper Companies | 14.85 Bn | 14.71 Bn | 735.40 Mn | 718.70 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 864.00 Mn |
| 10 | Harvard Bioscience | 33.72 Mn | 27.22 Mn | 12.63 Mn | 13.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.61 Mn |
| Mar 31, 2026 | 13.42 Mn |
| Dec 31, 2025 | 12.46 Mn |
| Sep 30, 2025 | 11.82 Mn |
| Jun 30, 2025 | 12.35 Mn |
| Mar 31, 2025 | 61.85 Mn |
| Dec 31, 2024 | 14.00 Mn |
| Sep 30, 2024 | 14.64 Mn |
| Jun 30, 2024 | 15.29 Mn |
| Mar 31, 2024 | 17.05 Mn |
| Dec 31, 2023 | 16.04 Mn |
| Sep 30, 2023 | 15.66 Mn |
| Jun 30, 2023 | 15.88 Mn |
| Mar 31, 2023 | 16.60 Mn |
| Dec 31, 2022 | 16.29 Mn |
| Sep 30, 2022 | 15.93 Mn |
| Jun 30, 2022 | 12.64 Mn |
| Mar 31, 2022 | 22.89 Mn |
| Dec 31, 2021 | 17.86 Mn |
| Sep 30, 2021 | 15.76 Mn |